Medication Overuse Headache / Rebound Headache Secondary to Migraine Headaches (Service-Connected)

Yes. Under 38 CFR § 3.310(a), any disability proximately caused or chronically worsened by a service-connected condition is itself service-connected. Medication Overuse Headache / Rebound Headache is a documented secondary pairing for Migraine Headaches (Service-Connected) with strong medical evidence. A nexus letter from a qualified physician linking the two conditions is the most reliable way to establish this connection.

The gold standard is a private nexus opinion stating — to at least a 50% probability ("at least as likely as not") — that the secondary condition was caused or aggravated by the primary service-connected condition. Peer-reviewed medical literature supporting the physiological mechanism strengthens the nexus. Treatment records documenting the onset or worsening of the secondary condition in temporal relation to the primary are supporting evidence.

The VA rates Medication Overuse Headache / Rebound Headache separately under its own 38 CFR Part 4 diagnostic code, then combines it with Migraine Headaches (Service-Connected) and all other service-connected ratings using the combined ratings formula under § 4.25. The formula applies the whole-person concept: a 50% combined existing rating plus a new 30% rating yields 65% (rounded to 70%), not 80%.

38 CFR § 3.310(a) states: "Disability which is proximately due to or the result of a service-connected disease or injury shall be service connected." The aggravation variant under § 3.310(b) applies where the primary condition permanently worsens a pre-existing disability beyond its natural progression. Both standards require a showing of nexus — a medical or scientific link between the primary condition and the secondary.

The medical evidence supporting Medication Overuse Headache / Rebound Headache as secondary to Migraine Headaches (Service-Connected) is rated strong. Treatment of service-connected migraines with acute medications (triptans, NSAIDs, ergotamines, opioids) at frequencies exceeding 10-15 days per month produces medication overuse headache (MOH) — a distinct clinical entity where the treatment itself perpetuates and worsens the headache condition. MOH occurs through receptor downregulation: chronic triptan use downregulates serotonin 5-HT1B/1D receptors, chronic NSAID use suppresses endogenous prostaglandin pain modulation, and chronic opioid use produces mu-receptor tolerance and opioid-induced hyperalgesia. MOH transforms episodic migraine into chronic daily headache, creating a more disabling condition than the original service-connected migraines. The withdrawal process is medically significant and often requires inpatient management.

The VA will not solicit nexus evidence on your behalf for secondary claims. In practice, a written nexus opinion from a private physician or independent medical examiner is essential — the VA's Compensation & Pension (C&P) examiner is not required to produce a favorable nexus opinion, and the VA has discretion to weigh competing opinions. Submitting a private nexus letter at the time of filing is the most reliable strategy.